Jagsonpal Pharmaceuticals to buy Group Pharmaceuticals' wellness portfolio for ₹47 crore

Jagsonpal Pharmaceuticals Ltd on Wednesday (September 23) said it will acquire the wellness portfolio of Group Pharmaceuticals Ltd for a total consideration of up to ₹46.7 crore through a slump sale.The company has entered into a Business Transfer Agreement with Group Pharmaceuticals for the acquis…